We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GAIA icon
1301
Gaia
GAIA
$48.4M
– –
-7,498
Closed -$69K
GBX icon
1302
The Greenbrier Companies
GBX
$1.46B
– –
-1,575
Closed -$51K
GEO icon
1303
The GEO Group
GEO
$4.04B
– –
-3,718
Closed -$71K
GGAL icon
1304
Galicia Financial Group
GGAL
$7.42B
– –
-79,836
Closed -$2.04M
GIC icon
1305
Global Industrial
GIC
$1.49B
– –
-9,663
Closed -$219K
GIII icon
1306
G-III Apparel Group
GIII
$1.5B
– –
-65,907
Closed -$2.63M
GKOS icon
1307
Glaukos
GKOS
$10.6B
– –
-696
Closed -$55K
GL icon
1308
Globe Life
GL
$14.3B
– –
-2,982
Closed -$244K
GLAD icon
1309
Gladstone Capital
GLAD
$446M
– –
-2,149
Closed -$39K
LKFT
1310
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
– –
-18,751
Closed -$2.21M
GLPI icon
1311
Gaming and Leisure Properties
GLPI
$12.8B
– –
-52,684
Closed -$2.03M
GMS
1312
DELISTED
GMS Inc
GMS
– –
-1,000
Closed -$15K
GNRC icon
1313
Generac Holdings
GNRC
$12.5B
– –
-15,066
Closed -$772K
B
1314
Barrick Mining
B
$73.2B
– –
-11,844
Closed -$162K
GPC icon
1315
Genuine Parts
GPC
$18.7B
– –
-389
Closed -$44K
GPRK icon
1316
GeoPark
GPRK
$612M
– –
-11,656
Closed -$201K
GSHD icon
1317
Goosehead Insurance
GSHD
$2.32B
– –
-286
Closed -$8K
GSK icon
1318
GSK
GSK
$106B
– –
-1,200
Closed -$62K
GTE icon
1319
Gran Tierra Energy
GTE
$317M
– –
-21,779
Closed -$494K
GTN icon
1320
Gray Television
GTN
$552M
– –
-106,094
Closed -$2.27M
GVA icon
1321
Granite Construction
GVA
$5.62B
– –
-700
Closed -$30K
GWW icon
1322
W.W. Grainger
GWW
$60.2B
– –
-700
Closed -$211K
GYRE icon
1323
Gyre Therapeutics
GYRE
$744M
– –
-217
Closed -$13K
H icon
1324
Hyatt Hotels
H
$16.7B
– –
-1,357
Closed -$98K
HAIN icon
1325
Hain Celestial
HAIN
$53.7M
– –
-201,601
Closed -$4.66M
51 52
53
54 55

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.